Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01188486 · ClinicalTrials.gov registry record · NA
Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01188486: Clinical Trial NA study, sponsored by Stanford University.
NCT01188486 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01188486, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The stereotactic body radiation therapy (SBRT) procedure is an emerging alternative to the standard treatment for early stage non-small cell lung cancer (NSCLC), typically lobectomy with lymphadenectomy. This procedure (lobectomy) does not fulfill the medical need as many patients are poor operative candidates or decline surgery. This study assesses the feasibility of stereotactic body radiation therapy (SBRT) as a tool to produce therapeutically useful computed tomography (CT) scans, using standard water-soluble iodinated compounds as the contrast agents.
Interventions
- RADIATION Stereotactic Body Radiation Therapy (SBRT)
- RADIATION Computed Tomography (CT)
- DEVICE Cyberknife
- DEVICE Trilogy
- DEVICE True Beam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2010-08 |
| Est. Completion | 2017-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01188486
The ClinicalTrials.gov registry entry for NCT01188486 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Stereotactic Body Radiation Therapy (SBRT) is the first listed.
NCT01188486 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01188486 about?
NCT01188486 is a clinical study titled "Pulmonary Interstitial Lymphography in Early Stage Lung Cancer". The stereotactic body radiation therapy (SBRT) procedure is an emerging alternative to the standard treatment for early stage non-small cell lung cancer (NSCLC), typically lobectomy with lymphadenectomy. This procedure (lobectomy) does not fulfill the medical need as many patients are poor operative...
What is the current status of trial NCT01188486?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2010-08. Estimated completion is 2017-04-30.
What interventions are being tested in trial NCT01188486?
The interventions under investigation include: Stereotactic Body Radiation Therapy (SBRT) (RADIATION), Computed Tomography (CT) (RADIATION), Cyberknife (DEVICE), Trilogy (DEVICE), True Beam (DEVICE).
Who is sponsoring clinical trial NCT01188486?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.